Targeting solid and hematologic cancers
Glioblastoma
The most common and malignant primary brain cancer.
Solid Cancers
Breast, ovarian and pancreatic cancer, and malignant meningioma.
Hematological Maligancies
Drug resistant acute lymphoblastic leukemia.
Therapeutic Platforms
First-in-class humanized and deimmunized pan-CD29 monoclonal antibody
Best-in-class humanized monoclonal antibody targeting PD1
Partners and Collaborators
